Abstract

Lynch Syndrome (LS) is an autosomal dominant disease conferring a high risk of colorectal cancer due to germline heterozygous mutations in a DNA mismatch repair (MMR) gene. Although cancers in LS patients show elevated somatic mutation burdens, information on mutation rates in normal tissues and understanding of the trajectory from normal to cancer cell is limited. Here we whole genome sequence 152 crypts from normal and neoplastic epithelial tissues from 10 LS patients. In normal tissues the repertoire of mutational processes and mutation rates is similar to that found in wild type individuals. A morphologically normal colonic crypt with an increased mutation burden and MMR deficiency-associated mutational signatures is identified, which may represent a very early stage of LS pathogenesis. Phylogenetic trees of tumour crypts indicate that the most recent ancestor cell of each tumour is already MMR deficient and has experienced multiple cycles of clonal evolution. This study demonstrates the genomic stability of epithelial cells with heterozygous germline MMR gene mutations and highlights important differences in the pathogenesis of LS from other colorectal cancer predisposition syndromes.

It is unclear whether somatic mutation rates are elevated in Lynch Syndrome (LS), which is the most common cause of hereditary colorectal cancer. Here, the authors use whole-genome sequencing and organoid cultures to show that normal tissues in LS patients are genomically stable, while ancestor cells of neoplastic tissues undergo multiple cycles of clonal evolution.

Details

Title
Mutational landscape of normal epithelial cells in Lynch Syndrome patients
Author
Lee Bernard C H 1 ; Robinson, Philip S 2   VIAFID ORCID Logo  ; Coorens Tim H H 3   VIAFID ORCID Logo  ; Yan Helen H N 1   VIAFID ORCID Logo  ; Olafsson Sigurgeir 3 ; Lee-Six, Henry 3 ; Sanders, Mathijs A 3 ; Siu Hoi Cheong 1 ; Hewinson, James 3 ; Yue Sarah S K 1 ; Tsui, Wai Yin 1 ; Chan Annie S Y 1 ; Chan Anthony K W 1 ; Ho, Siu Lun 1 ; Campbell, Peter J 3   VIAFID ORCID Logo  ; Martincorena Inigo 3   VIAFID ORCID Logo  ; Buczacki Simon J A 4 ; Yuen, Siu Tsan 1 ; Leung, Suet Yi 5   VIAFID ORCID Logo  ; Stratton, Michael R 3   VIAFID ORCID Logo 

 The University of Hong Kong, Queen Mary Hospital, Hereditary Gastrointestinal Cancer Genetic Diagnosis Laboratory, Department of Pathology, School of Clinical Medicine, Pokfulam, Hong Kong (GRID:grid.194645.b) (ISNI:0000000121742757) 
 Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382); University of Cambridge, Department of Paediatrics, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382) 
 University of Oxford, Headington, Nuffield Department of Surgical Sciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 The University of Hong Kong, Queen Mary Hospital, Hereditary Gastrointestinal Cancer Genetic Diagnosis Laboratory, Department of Pathology, School of Clinical Medicine, Pokfulam, Hong Kong (GRID:grid.194645.b) (ISNI:0000000121742757); The University of Hong Kong, Centre for PanorOmic Sciences, Pokfulam, Hong Kong (GRID:grid.194645.b) (ISNI:0000000121742757) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2665414140
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.